Choice of preparation

Atrial fibrillation. Choice of anticoagulant.

February 15, 2017
The material describes a rational approach to choosing an anticoagulant for atrial fibrillation.

The choice of a drug for cough treatment in ARI of various etiologies

January 26, 2017
The material presents the key groups of modern antitussive drugs.

Sprays for the throat. Key Features

December 02, 2016
This material describes the features of the most popular throat sprays in Russia in terms of the active ingredient, age limitations, and also during pregnancy and lactation.

Choosing an anticoagulant for atrial fibrillation

December 1, 2016
Prevention of thromboembolic complications is an important link in the therapy of atrial fibrillation. For many years warfarin was in fact the only drug prescribed for this purpose. However, it has a number of significant shortcomings, the most significant of which is the need to constantly monitor the international normalized attitude in outpatient settings. This gives patients a huge inconvenience, which is extremely adversely affected

Myoma of the uterus. Choice of preparation

November 20, 2016
The material presents the advantages and disadvantages of the main classes of drugs that are used to treat uterine fibroids.

Dydrogesterone or micronized progesterone: what to prefer?

November 13, 2016
Progesterone deficiency underlies many different gynecological diseases. In the English-language literature this phenomenon is called "luteal phase dysfunction" (dysfunction of the luteal phase). Its manifestations include dysfunctional uterine bleeding, infertility, premenstrual syndrome, threatening abortion, endometriosis and other common diseases.For the treatment of dysfunction of the luteal phase,

Nonspecific therapy for cirrhosis. Choice of preparation

November 1, 2016
For some types of cirrhosis there is a specific treatment. For example, with primary biliary cirrhosis, ursodeoxycholic acid preparations are effective. With cirrhosis of the liver against the background of autoimmune hepatitis, glucocorticoids and cytostatics are used. In case of viral hepatitis C, appropriate antiviral therapy regimens are prescribed. However, there is a list of drugs that have a significant pathogenetic effect in cirrhosis

Chronic obstructive pulmonary disease. Selection of M-cholinoblocker

October 18, 2016
Inhaled M-holinoblokatory are the key drugs in chronic obstructive pulmonary disease for both relief of symptoms and maintenance therapy. A large number of preparations of this group are presented on the market, which differ both in the active substance and in the device of the inhaler.

Aspirin in primary prevention of cardiovascular diseases

October 13, 2016

In this material, the most current,based on evidence information on the use of aspirin for primary prevention of cardiovascular disease.

Vaccine against the flu. How to choose?

October 7, 2016
Influenza has been and remains an epidemiological problem of a global scale. The disease is characterized by considerable morbidity and mortality, and currently available etiotropic therapy does not have sufficient efficacy. In this regard, the World Health Organization and the Ministry of Health of Russia recommend mass vaccination of the population in the autumn-winter period, when the likelihood of infection is maximized. Each year the composition of vaccines

Laxatives in uncomplicated cases of constipation

September 28, 2016
Constipation (constipation) is one of the most frequent complaints from patients of any profile. To treat uncomplicated cases of constipation, there is a huge selection of laxatives. The material presents a classification of the latter on the basis of modern scientific concepts.

Anti-VEGF drugs in the treatment of retinal vascular diseases

September 23, 2016
VEGF (from English "vascular endothelial growth factor") is a growth factor that stimulates neoplasm of blood vessels.The excess of this factor plays a big role in the pathogenesis of some retinal diseases, such as age-related exudative macular degeneration and diabetic macular edema. Today, various biological preparations with anti-VEGF activity have been developed for the treatment of these diseases.
  • 1